Skip to content

CASI PHARMACEUTICALS, INC.: 10-Q filed 2019-08-09

What CASI PHARMACEUTICALS, INC. reported in its quarterly report filed 2019-08-09 (fiscal Q2 2019): 35 published measures, 83 facts as tagged in accession 0001144204-19-038740.

This filing

Form
10-Q (quarterly report)
Filed
2019-08-09
Fiscal period
fiscal Q2 2019
Accession
0001144204-19-038740 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CASI PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-06-30117,090,260USD
At 2018-12-31113,410,001USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-06-307,815,793USD
At 2018-12-313,947,535USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-06-3089,037,633USD
At 2019-03-31104,196,246USD
At 2018-12-31109,462,466USD
At 2018-06-3083,522,144USD
At 2018-03-3167,619,020USD
At 2017-12-3138,540,114USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-06-3070,251,858USD
At 2018-12-3184,204,809USD
At 2018-06-3066,215,678USD
At 2017-12-3143,489,935USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-15,313,171USD91
2019-01-01 to 2019-06-30-23,486,792USD181
2018-04-01 to 2018-06-30-5,859,783USD91
2018-01-01 to 2018-06-30-9,450,694USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-13,676,589USD181
2018-01-01 to 2018-06-30-9,345,445USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-06-30331,437USD181
2018-01-01 to 2018-06-30726,445USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-04-01 to 2019-06-300USD91
2019-01-01 to 2019-06-300USD181
2018-04-01 to 2018-06-300USD91
2018-01-01 to 2018-06-300USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-06-3020,713,829USD181
2018-01-01 to 2018-06-3051,927,835USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-06-30-20,218,294USD181
2018-01-01 to 2018-06-30-19,334,293USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-06-30-502,428,077USD
At 2018-12-31-478,941,285USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-06-301,335,330USD
At 2018-12-311,750,630USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-01-01 to 2019-06-303,309,408USD181
2018-01-01 to 2018-06-301,812,219USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-06-3080,609,312USD
At 2018-12-3192,564,620USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-06-306,182,532USD
At 2018-12-313,873,944USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-06-302,321,499USD
At 2018-12-31968,048USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-06-30672,697USD
At 2018-12-31282,709USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-06-3095,717,052shares
At 2018-12-3195,287,268shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-06-30600,569,013USD
At 2018-12-31596,710,648USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-06-30-2,027,024USD
At 2018-12-31-1,226,320USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2019-06-302,716,440USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2019-06-302,780,300USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2019-06-3018,191,694USD
At 2018-12-3118,784,727USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-06-303,056,164USD
At 2018-12-31310,024USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-06-301,633,261USD
At 2018-12-3173,591USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-06-302,361,276USD
At 2018-12-311,406,434USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2019-06-308,968,099USD
At 2018-12-317,164,902USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-15,251,270USD91
2019-01-01 to 2019-06-30-23,410,532USD181
2018-04-01 to 2018-06-30-5,859,783USD91
2018-01-01 to 2018-06-30-9,450,694USD181

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-04-01 to 2019-06-30-16,425,660USD91
2019-01-01 to 2019-06-30-24,287,496USD181
2018-04-01 to 2018-06-30-6,926,676USD91
2018-01-01 to 2018-06-30-9,990,336USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-04-01 to 2019-06-306,982,227USD91
2019-01-01 to 2019-06-3012,691,914USD181
2018-04-01 to 2018-06-304,042,347USD91
2018-01-01 to 2018-06-305,345,469USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-06-30624,014USD181
2018-01-01 to 2018-06-30141,717USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-01-01 to 2019-06-30775,305USD181
2018-01-01 to 2018-06-30597,354USD181

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2019-01-01 to 2019-06-300USD181
2018-01-01 to 2018-06-300USD181

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2019-01-01 to 2019-06-30610,904USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-06-30389,988USD181
2018-01-01 to 2018-06-30429,973USD181

Inspect the source

Entity
CASI PHARMACEUTICALS, INC. / CIK 0000895051
Captured
SEC response SHA-256
a5465bb63979ec441cdd2d0b7761265dc0541f5ee25dcdffded348a960f99c09

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000895051.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))